RMB Capital Management »

An2 Therapeutics shares owned by RMB Capital Management

Quarter-by-quarter ownership of An2 Therapeutics (ANTX) shares owned by RMB Capital Management from 13F filings

Historical chart of RMB Capital Management investment in An2 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including An2 Therapeutics held by RMB Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in An2 Therapeutics by RMB Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $941k 46k 20.49
2023-09-30 $739k 46k 16.08

More positions owned by RMB Capital Management

Microsoft Corporation (MSFT)
Visa Com Cl A (V)
Apple (AAPL)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ptc (PTC)
Alphabet Cap Stk Cl A (GOOGL)
salesforce (CRM)
S&p Global (SPGI)
Synopsys (SNPS)
Tyler Technologies (TYL)
Alphabet Cap Stk Cl C (GOOG)
Booking Holdings (BKNG)
Steris Shs Usd (STE)

View all positions for RMB Capital Management

Top funds holding An2 Therapeutics

RA Capital Management
Citadel Advisors
Frazier Life Sciences Management
BVF
Henderson Group
Avidity Partners Management
Octagon Capital Advisors
Vanguard Group
Adage Capital Partners GP
BlackRock
Susquehanna International
Geode Capital Management
Acadian Asset Management
Walleye Trading Advisors
Alyeska Investment Group

View all funds holding An2 Therapeutics